Drug intelligence / Profile preview

cefradine

Development stage
Unknown
Lead developer
Eli Lilly
Modality
Small Molecules
Administration
Oral, Intravenous, Intramuscular
01

Overview

Cefradine is a first-generation, semi-synthetic cephalosporin antibiotic belonging to the beta-lactam class. It is used in the treatment of a variety of bacterial infections including those of the respiratory tract (such as tonsillitis, pharyngitis, and pneumonia), urinary tract (including prostatitis), skin and soft tissues, ear (otitis media), and sinusitis. Cefradine acts by binding to penicillin-binding proteins inside bacterial cell walls, inhibiting the final stage of peptidoglycan synthesis required for cell wall integrity. This disruption leads to cell lysis and death via activation of autolytic enzymes within bacteria[1][2][3][7][8]. Its spectrum of activity is similar to that of cefalexin. Cefradine is not approved by the FDA for use in the United States but has been marketed under various brand names elsewhere.

Brand names
Velosef
Other names
cephradinecephradinRAD
02

Targets

PBP1A (Penicillin-binding protein 1A)

Beyond the preview

Go deeper on cefradine.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on cefradine.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call